DocGo Inc. (NASDAQ:DCGO) Short Interest Update

DocGo Inc. (NASDAQ:DCGO) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 7,710,000 shares, an increase of 17.5% from the February 13th total of 6,560,000 shares. Based on an average daily trading volume, of 759,000 shares, the short-interest ratio is currently 10.2 days. Approximately 8.8% of the company’s shares are sold short.

Institutional Investors Weigh In On DocGo

Several hedge funds have recently bought and sold shares of the company. Jefferies Financial Group Inc. acquired a new stake in DocGo in the 4th quarter valued at about $123,000. Mackenzie Financial Corp bought a new position in DocGo in the 4th quarter valued at about $579,000. Squarepoint Ops LLC raised its holdings in DocGo by 65.5% in the 4th quarter. Squarepoint Ops LLC now owns 66,260 shares of the company’s stock valued at $281,000 after acquiring an additional 26,221 shares during the period. State of Wyoming raised its holdings in DocGo by 55.1% in the 4th quarter. State of Wyoming now owns 159,033 shares of the company’s stock valued at $674,000 after acquiring an additional 56,500 shares during the period. Finally, ProShare Advisors LLC raised its holdings in DocGo by 49.0% in the 4th quarter. ProShare Advisors LLC now owns 28,641 shares of the company’s stock valued at $121,000 after acquiring an additional 9,425 shares during the period. 56.44% of the stock is currently owned by institutional investors and hedge funds.

DocGo Trading Down 0.7 %

DCGO stock opened at $2.82 on Thursday. The stock has a 50-day moving average price of $4.26 and a two-hundred day moving average price of $3.97. The stock has a market cap of $287.59 million, a PE ratio of 10.07, a price-to-earnings-growth ratio of 14.16 and a beta of 1.08. DocGo has a 1 year low of $2.75 and a 1 year high of $5.68.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. Needham & Company LLC lowered their price objective on shares of DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a research report on Friday, February 28th. Stifel Nicolaus lowered their price objective on shares of DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Finally, Deutsche Bank Aktiengesellschaft cut shares of DocGo from a “buy” rating to a “hold” rating and lowered their price objective for the company from $5.00 to $2.85 in a research report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $4.89.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.